Due to presumably sustained activation of STAT5 in this MLL-rearranged ALL, STAT5A silencing was more beneficial and promoted proliferation inhibition, possibly by downregulating PIM-2 [54, 55]. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.